BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16077362)

  • 1. HIV-associated retinopathy in the HAART era.
    Goldberg DE; Smithen LM; Angelilli A; Freeman WR
    Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
    Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
    AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy.
    Goldberg DE; Wang H; Azen SP; Freeman WR
    Br J Ophthalmol; 2003 Jul; 87(7):853-5. PubMed ID: 12812884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
    Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
    Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
    AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMV retinitis in the era of HAART.
    Cassoux N; Bodaghi B; Katlama C; LeHoang P
    Ocul Immunol Inflamm; 1999 Dec; 7(3-4):231-5. PubMed ID: 10611732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field loss in patients with cytomegalovirus retinitis.
    Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
    Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
    Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
    Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.